Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea - Wikidata - wikimedia - TriplyDB

Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea

Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea

http://www.wikidata.org/entity/Q34977189

about

Is radiation-induced ovarian ablation in breast cancer an obsolete procedure? Results of a meta-analysis.Evaluating the Survival Benefit Following Ovarian Function Suppression in Premenopausal Patients with Hormone Receptor Positive Early Breast Cancer.

P2860

Q36053796-6D63C4D4-BD16-449D-A6FF-66FBB577FC77 Q36941307-F9A1C120-1914-4530-92F0-BDB65ABEFD64

P2860

Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea

http://www.wikidata.org/entity/Q34977189

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ovarian Ablation Using Goserel ...... hemotherapy-Induced Amenorrhea

@ast

Ovarian Ablation Using Goserel ...... hemotherapy-Induced Amenorrhea

@en

Ovarian Ablation Using Goserel ...... hemotherapy-Induced Amenorrhea

@nl

type

label

Ovarian Ablation Using Goserel ...... hemotherapy-Induced Amenorrhea

@ast

Ovarian Ablation Using Goserel ...... hemotherapy-Induced Amenorrhea

@en

Ovarian Ablation Using Goserel ...... hemotherapy-Induced Amenorrhea

@nl

prefLabel

Ovarian Ablation Using Goserel ...... hemotherapy-Induced Amenorrhea

@ast

Ovarian Ablation Using Goserel ...... hemotherapy-Induced Amenorrhea

@en

Ovarian Ablation Using Goserel ...... hemotherapy-Induced Amenorrhea

@nl

P1433

Q34977189-A1EF31FF-9D8F-462C-BA7B-29EE0CB38F2E

P1476

Q34977189-93D9C1D3-4D63-4F68-A179-8892DCF9B1D6

P2093

Q34977189-0597E405-DFCA-4BDD-B119-08C68B43483B

Q34977189-0A07CFEC-95A2-4522-B508-259FD6FE32A0

Q34977189-7FBA9FFB-C40F-47F5-950A-3BDE18F49EA2

Q34977189-81C22C8D-C349-4393-A2B7-E305F43B19AA

Q34977189-AB1C45E5-B00E-4414-8A40-2FA8234CBDD8

Q34977189-C7655A07-E2ED-403E-83F2-6CF83397C9C9

Q34977189-CEF01A80-8DCE-41DD-84FA-E092117623CC

Q34977189-D5F91931-2387-459E-887E-7B081C4E26F3

P2860

Q34977189-11CA0F0A-F8CF-417D-9EA5-D93EA0F4D4C1

Q34977189-14D2742B-F9CE-47EA-91B6-49E789B8B724

Q34977189-1AE9508D-7676-4B38-8BCC-1AD67BCAF4F6

Q34977189-21282A1B-4C20-49AF-B56E-573AD906BA1D

Q34977189-269C5335-C2A0-490A-84C6-A58F7124218F

Q34977189-4DD137F4-5297-435C-9DBE-4D097EC5610D

Q34977189-51565B69-AD6F-41C2-B6B6-E6EA289D12DF

Q34977189-80D1A33E-6A63-483E-9BE3-E1C1300C89A5

Q34977189-84D96D67-6D43-48AC-9A76-59DA234CD37B

Q34977189-89DE5186-F7D8-4D9E-826A-3900171B37D7

P304

Q34977189-C67CFDE4-90DD-4413-BA9A-CD88709A42E2

P31

Q34977189-DC84DAB2-6389-4B99-A7B4-77AE3A350DD4

P356

Q34977189-E12F8105-8EBD-4B04-A1F6-9A1FFAA08955

P433

Q34977189-A6DC5AB2-E166-4FEF-9C19-8F0D9E153E21

P478

Q34977189-D3499591-B813-488E-9D6D-F620E31710D7

P577

Q34977189-08E98EF2-BD1A-46B3-8344-6D4C53928C22

P5875

Q34977189-986FE242-D34C-4F5A-ABA3-0B54A00D79E6

P698

Q34977189-BAF082ED-4873-4E14-93F6-7F7DB09D10C4

P921

Q34977189-671CC6D7-871F-4B3C-8F86-9F9A7BACA00E

P932

Q34977189-FDC89AE8-F9B8-4590-BB9E-86B14F33EF37

P356

P1433

Cancer Research and Treatment

P1476

Ovarian Ablation Using Goserel ...... hemotherapy-Induced Amenorrhea

@en

P2093

Feng-Yan Li

http://www.w3.org/2001/XMLSchema#string

Huan-Xin Lin

http://www.w3.org/2001/XMLSchema#string

Jia-Yuan Sun

http://www.w3.org/2001/XMLSchema#string

Juan Zhou

http://www.w3.org/2001/XMLSchema#string

Jun-Jie Wang

http://www.w3.org/2001/XMLSchema#string

Qin Lin

http://www.w3.org/2001/XMLSchema#string

San-Gang Wu

http://www.w3.org/2001/XMLSchema#string

Zhen-Yu He

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer.

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.

Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review.

A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China.

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.

Role of goserelin in combination with endocrine therapy for the treatment of advanced breast cancer in premenopausal women positive for hormone receptor: a retrospective matched case-control study.

P304

55-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4143/CRT.2013.165

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265344404

http://www.w3.org/2001/XMLSchema#string

P698

25187267

http://www.w3.org/2001/XMLSchema#string

P921

P932

4296851

http://www.w3.org/2001/XMLSchema#string